https://www.selleckchem.com/pr....oducts/piperaquine-p
A total of 58% have hormone receptor-positive/human epidermal growth factor receptor 2-negative tumors, 25% are human epidermal growth factor receptor 2-positive, and 16% have triple-negative breast cancer. According to our methodology, the estimated median overall survival of Brazilian women after diagnosis of MBC is 26.2 months. CONCLUSION The significant number of patients living with MBC should inform and raise the interest of the many stakeholders involved. This collaborative effort is a clear requirement to improve t
Respect!
Kommentar
Delen
